Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v10-EN
Language French English
Date Updated 2019-12-24 2019-12-24
Drug Identification Number 02379848 02379848
Brand name MONTELUKAST MONTELUKAST
Common or Proper name MONTELUKAST MONTELUKAST
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients MONTELUKAST MONTELUKAST
Strength(s) 5MG 5MG
Dosage form(s) TABLET (CHEWABLE) TABLET (CHEWABLE)
Route of administration ORAL ORAL
Packaging size 30 30
ATC code R03DC R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-11-26 2019-11-26
Estimated end date 2019-12-20 2019-12-20
Actual end date 2019-12-20 2019-12-20
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments